Literature DB >> 33353807

Exploring the potential intracellular targets of vascular normalization based on active candidates.

Yuanyuan Shan1, Jin Wang2, Ru Si2, Yuexiang Ma2, Jing Li2, Qingqing Zhang2, Wen Lu3, Jie Zhang4.   

Abstract

We previously developed two candidates with potency of inducing vascular normalization, BD7 and B14. However, the definite intracellular molecular target(s) responsible for their activity remains unknown. Herein, we report the discovery and functional assessment of several multifunctional photoaffinity probes for determining the potential biological targets of active compounds. The probes bear a photoaffinity moiety and a bioorthogonal unit attached to B7 or B14 and maintained the bioactivity of the parent active molecules. Using in vitro biological assays, we preliminarily identified VEGFR-2 as a potential intracellular target for the active candidates. Our results demonstrate the utility of these multifunctional photoaffinity probes for analyzing the biological activity and subcellular localization of the intracellular target proteins of active candidates.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Anti-angiogesis agents; Intracellular target; Multifunctional photoaffinity probe; Vascular normalization

Year:  2020        PMID: 33353807     DOI: 10.1016/j.bioorg.2020.104551

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  Photoaffinity Probe Reveals the Potential Target of Harringtonolide for Cancer Cell Migration Inhibition.

Authors:  Tian-Yu Zhu; Xiu-Tao Wu; Chen Chen; Xiao-Qin Liu; Li Zhu; Jian-Guang Luo; Ling-Yi Kong
Journal:  ACS Med Chem Lett       Date:  2022-02-02       Impact factor: 4.345

2.  The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2.

Authors:  Sittisak Oekchuae; Jitnapa Sirirak; Purin Charoensuksai; Pawaris Wongprayoon; Natthaya Chuaypen; Jutatip Boonsombat; Somsak Ruchirawat; Pisit Tangkijvanich; Apichart Suksamrarn; Panupun Limpachayaporn
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.